Clinical Trial Update: Use of MCT Oil for Enhancement of Weight Loss and Glycemic Control in Obese Diabetic Patients [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/Phase 2 clinical trial evaluating medium-chain triglyceride (MCT) oil for weight loss and glycemic control in obese individuals with Type 2 …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• MCT Oil (medium-chain triglyceride oil)

Snippet

Sponsor: Boston Medical Center | Conditions: Obesity, Type 2 Diabetes Mellitus | Phase 1, Phase 2 | Status: COMPLETED